UMB Bank n.a. Grows Stock Holdings in Teradyne, Inc. $TER

UMB Bank n.a. boosted its holdings in Teradyne, Inc. (NASDAQ:TERFree Report) by 250.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,112 shares of the company’s stock after buying an additional 1,510 shares during the period. UMB Bank n.a.’s holdings in Teradyne were worth $190,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of the business. Vanguard Group Inc. grew its stake in Teradyne by 2.5% in the 1st quarter. Vanguard Group Inc. now owns 20,922,231 shares of the company’s stock valued at $1,728,176,000 after buying an additional 516,332 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. grew its stake in Teradyne by 4.6% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,957,049 shares of the company’s stock valued at $244,252,000 after buying an additional 131,152 shares in the last quarter. Invesco Ltd. grew its stake in Teradyne by 16.1% in the 1st quarter. Invesco Ltd. now owns 2,790,898 shares of the company’s stock valued at $230,528,000 after buying an additional 387,705 shares in the last quarter. Allspring Global Investments Holdings LLC grew its stake in Teradyne by 3.1% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 2,466,122 shares of the company’s stock valued at $203,726,000 after buying an additional 75,226 shares in the last quarter. Finally, ARK Investment Management LLC grew its stake in Teradyne by 16.7% in the 1st quarter. ARK Investment Management LLC now owns 2,243,590 shares of the company’s stock valued at $185,321,000 after buying an additional 320,580 shares in the last quarter. 99.77% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Teradyne

In related news, CEO Gregory Stephen Smith sold 554 shares of the stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $115.00, for a total value of $63,710.00. Following the completion of the transaction, the chief executive officer directly owned 96,439 shares of the company’s stock, valued at $11,090,485. This represents a 0.57% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders have sold 1,662 shares of company stock valued at $181,008 over the last ninety days. 0.16% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on TER shares. JPMorgan Chase & Co. restated a “neutral” rating and set a $102.00 price target (up from $88.00) on shares of Teradyne in a research report on Thursday, July 17th. The Goldman Sachs Group restated a “sell” rating and set a $85.00 price target on shares of Teradyne in a research report on Wednesday, July 30th. Stifel Nicolaus boosted their price target on shares of Teradyne from $85.00 to $100.00 and gave the company a “hold” rating in a research report on Thursday, July 31st. Cowen restated a “buy” rating on shares of Teradyne in a research report on Wednesday, July 30th. Finally, Wall Street Zen upgraded shares of Teradyne from a “sell” rating to a “hold” rating in a research report on Monday, September 1st. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $118.63.

Check Out Our Latest Research Report on TER

Teradyne Trading Down 0.4%

Shares of NASDAQ:TER opened at $134.68 on Wednesday. The company has a market cap of $21.42 billion, a price-to-earnings ratio of 46.60, a price-to-earnings-growth ratio of 2.84 and a beta of 1.80. The company has a 50-day moving average price of $109.96 and a 200-day moving average price of $92.21. Teradyne, Inc. has a 12 month low of $65.77 and a 12 month high of $144.16.

Teradyne (NASDAQ:TERGet Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $0.57 EPS for the quarter, beating the consensus estimate of $0.54 by $0.03. Teradyne had a net margin of 16.59% and a return on equity of 18.16%. The firm had revenue of $651.80 million during the quarter, compared to the consensus estimate of $649.02 million. During the same period in the prior year, the firm posted $0.86 earnings per share. The company’s quarterly revenue was down 10.7% compared to the same quarter last year. Teradyne has set its Q3 2025 guidance at 0.690-0.870 EPS. As a group, research analysts forecast that Teradyne, Inc. will post 3.88 EPS for the current fiscal year.

Teradyne Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, September 29th. Investors of record on Friday, September 5th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Friday, September 5th. Teradyne’s dividend payout ratio is presently 16.61%.

Teradyne Profile

(Free Report)

Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.

Read More

Want to see what other hedge funds are holding TER? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teradyne, Inc. (NASDAQ:TERFree Report).

Institutional Ownership by Quarter for Teradyne (NASDAQ:TER)

Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.